Corteva’s $35 million deal targets the rebates that kept cheaper pesticides out
The proposed settlement would loosen restrictions on distributors, opening a path for generic competitors after patents expire.
Corteva has agreed to pay $35 million to states and change a pesticide loyalty program that regulators say blocked cheaper generic competition, in a proposed settlement announced September 28.
The Federal Trade Commission and state attorneys general challenged the company's use of rebates that rewarded distributors for limiting purchases from rival suppliers. The allegation is that farmers continued paying more even after patent protections expired and generic products could otherwise compete.
California Attorney General Rob Bonta said the agreement would limit the loyalty arrangements and restore opportunities for generic manufacturers. The $35 million payment goes to the plaintiff states; it should not be described as an announced $35 million refund fund for individual farmers.
Why distribution matters
A patent's expiration does not guarantee that a generic manufacturer can reach customers. In this case, regulators argued that incentives offered to distributors created a barrier between competing products and the farmers who might buy them.
The alleged mechanism was a purchasing threshold: distributors could lose benefits if they bought too much of a competing generic. That can make a cheaper product less attractive to stock even when its price is lower, because the distributor must weigh the potential loss of rebates elsewhere in its business.
The FTC's account describes that as exclusionary conduct rather than ordinary price competition. The settlement addresses the program's structure; it does not set a universal selling price for pesticides.
A decade of restrictions
Washington state's attorney general says the proposed order would, for ten years, prohibit Corteva from conditioning benefits on distributors purchasing a high share of the relevant active ingredients from Corteva or similarly restricting purchases of generics.
That duration is significant for companies deciding whether to enter or expand in the market. The objective is to remove a continuing distribution obstacle, rather than provide only a one-time financial payment.
The agreement follows litigation begun in 2022. FTC case records say the proposed stipulated order was filed September 25 and publicly announced September 28. The lawsuit also involved Syngenta, but the Corteva settlement should not be presented as resolving every claim against every defendant.
What farmers can expect
More room for generic competition can expand purchasing options. It does not establish how much a particular farm will save, which products its distributor will stock or when quoted prices will change. Those outcomes depend on the products available and the decisions of suppliers and buyers.
The concrete change proposed here is the removal of specified loyalty conditions for a ten-year period, alongside the payment to states. Court approval and compliance with those terms are the next steps in putting the agreement into effect.